Ellen ‘t Hoen | Medicines Law & Policy | Page 2

37 POSTS 0 COMMENTS

http://medicineslawandpolicy.org

Strong call for transparency on medicine prices, cost of R&D at WHO Fair Pricing...

Ellen 't Hoen - April 19, 2019

Humiragate: AbbVie’s desperate attempts to keep its monopoly

Ellen 't Hoen - March 27, 2019

Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in patent law.

Ellen 't Hoen - February 22, 2019

Cystic Fibrosis Medicines Wars in Europe

Ellen 't Hoen - February 3, 2019

Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda

Ellen 't Hoen - January 23, 2019

Time to put a stop to the abuse of orphan drug regulation- the latest...

Ellen 't Hoen - January 9, 2019

2018 Round-up of Noteworthy Medicines Law and Policy Events

Ellen 't Hoen - December 26, 2018

New Database Documents the Power of TRIPS Flexibilities

Ellen 't Hoen - November 27, 2018

WIPO and pharma industry launch global medicines patent database

Ellen 't Hoen - September 27, 2018

Dutch health insurance company Menzis takes AstraZeneca to court over patent evergreening

Ellen 't Hoen - September 20, 2018

123 4 Page 2 of 4